Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Post-Operative Analgesia in Alcohol-Dependent Patients
NCT00329394Phase 3Suspended
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Apr 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ketamine in postoperative pain and alcohol withdrawal syndrome (AWS) (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Average consumption of morphine at 48 hours. Started Apr 2006; status: suspended.
02
Drugs
ketamine
03
Conditions
postoperative painalcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT00329394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329394.